Benadryl
Infusion Reaction
Providence Health & ServicesPhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Infusion Reaction cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DEXAMETHASONE Shanghai Pulmonary Hospital, Shanghai, China | Phase 4 | BBB |
CETIRIZINE Providence Health & Services | Phase 3 | B |
Miglustat University of Florida | Phase 1 | CC |
Same molecule, other indications
Benadryl is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →